Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. (2022)
Attributed to:
Evaluating new healthcare technologies in cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2021.103802
PubMed Identifier: 34990893
Publication URI: http://europepmc.org/abstract/MED/34990893
Type: Journal Article/Review
Volume: 75
Parent Publication: EBioMedicine
ISSN: 2352-3964